Reproduction

Pricing of Debt

Retrieved on: 
Wednesday, April 10, 2024
KID, Regulation, Reproduction, Person, Property management

Any forwarding, distribution or reproduction of the Final Terms or the Offering Circular in whole or in part is prohibited.

Key Points: 
  • Any forwarding, distribution or reproduction of the Final Terms or the Offering Circular in whole or in part is prohibited.
  • Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions.
  • Manufacturer target market (EU MiFID II and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels).
  • No EU PRIIPs or UK PRIIPs key information document (KID) has been prepared as not available to retail in EEA or in the UK.

EQS-News: G.ST Antivirals reports start of Phase II trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer

Retrieved on: 
Wednesday, April 10, 2024
JAMA, Recreational vehicle, Metabolism, CHDR, Entrepreneurship, Dean (education), Viral, Reproduction, University, Head, Volunteering, MD, Urinary tract infection, Infection, Medical school, Clinical trial, Pharmacokinetics, Southern Illinois University, Division, Virus, CMO, University School, Glycolysis, Pharmaceutical industry

An expert in the clinical research of respiratory viruses, Dr. Turner will oversee the Company’s current clinical trial and drive further clinical development.

Key Points: 
  • An expert in the clinical research of respiratory viruses, Dr. Turner will oversee the Company’s current clinical trial and drive further clinical development.
  • This study aims to assess the effectiveness of 2-DG in preventing illness from rhinoviruses, reducing infection rates, and easing symptom severity.
  • A total of 128 volunteers will participate, receiving up to four daily intranasal doses of either 2-DG or a placebo.
  • 2-DG is a unique and intriguing therapeutic approach to treating viral infections by blocking the virus’ nutrient access,” commented Ronald Bruce Turner, MD, CMO of G.ST Antivirals.

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements

Retrieved on: 
Tuesday, April 9, 2024
Shenzhen University, Molecular biology, Immunology, Nature Methods, Advanced technology, Proteome, Ageing, Speech, Genesis (journal), Data analysis, Southern Medical University, Neuroscience, Translation, Human Cell Atlas, Nature Communications, Biochemistry, Neurology, Communication, Transcriptome, Genetics, Research, Genome, Epigenome, Immunity, Microbiology, Metabolome, Diagnosis, Peking University, Health, Conference, GSA, Executive, Cancer, Fudan University, Reproduction, Biology, National academy, Zhejiang University, Medicine

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.

Key Points: 
  • SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.
  • With the theme "Technologic Innovation, Scientific Discovery, Translational Application", TICSSO-2 focused on the latest advances in single-cell and spatial omics.
  • On March 31st and April 1st were four online international forums, with one specifically for young researchers.
  • TICSSO-2 is hailed as the largest, most influential, and highest academic conference in the field of single-cell and spatial omics in the world.

Survey on the Access to Finance of Enterprises: firms report moderate tightening of financing conditions

Retrieved on: 
Tuesday, April 9, 2024
Access, SAFE, Reproduction, Frankfurt, Growth, Communication, European Central Bank

The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.

Key Points: 
  • The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.
  • The Guidelines provide a common approach to the resubmission of historical data by the financial institutions to the competent and resolution authorities in case of errors, inaccuracies or other changes in the data reported, in accordance with the supervisory and resolution reporting framework developed by the EBA.

April 2024 euro area bank lending survey

Retrieved on: 
Tuesday, April 9, 2024
Reproduction, Pressure, BLS, ECB, Frankfurt, Policy, Communication, Credit, Housing, European Central Bank, Bank

The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.

Key Points: 
  • The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.
  • The Guidelines provide a common approach to the resubmission of historical data by the financial institutions to the competent and resolution authorities in case of errors, inaccuracies or other changes in the data reported, in accordance with the supervisory and resolution reporting framework developed by the EBA.

Survey on the Access to Finance of Enterprises in the euro area - First quarter of 2024

Retrieved on: 
Tuesday, April 9, 2024
Reproduction, SAFE, European Central Bank, Employment, HTML, PDF, BLS, Growth, Section 3, ECB, Q10, Risk, Buffer, Attitude, Website, Methodology, Chart, Investment, Access, Data, SME, Section 2, Q23, Security (finance)

The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.

Key Points: 
  • The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.
  • The Guidelines provide a common approach to the resubmission of historical data by the financial institutions to the competent and resolution authorities in case of errors, inaccuracies or other changes in the data reported, in accordance with the supervisory and resolution reporting framework developed by the EBA.

The euro area bank lending survey - First quarter of 2024

Retrieved on: 
Tuesday, April 9, 2024
Reproduction, PDF, Pressure, BLS, Growth, Finance, ECB, Risk, Bank, Knowledge, Website, Table, Overalls, Credit, Housing, Competition, GDP, High Council, Outright Monetary Transactions, SME

The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.

Key Points: 
  • The European Banking Authority (EBA) today published its final Guidelines on the resubmission of historical data under the EBA reporting framework.
  • The Guidelines provide a common approach to the resubmission of historical data by the financial institutions to the competent and resolution authorities in case of errors, inaccuracies or other changes in the data reported, in accordance with the supervisory and resolution reporting framework developed by the EBA.

TLI Investigator Dr. Wei Yan Named Editor-in-Chief of the Andrology Journal

Retrieved on: 
Monday, March 18, 2024
Reproduction, Lundquist, Managing editor, Infertility, SSR, Male, Social media, Research, Fertility, Doctor of Philosophy, MD, Biology of Reproduction, Society, ELife, Biology, Reproductive medicine, UCLA, Management

Dr. Yan's appointment to Andrology is a testament to his dedication to reproductive medicine.

Key Points: 
  • Dr. Yan's appointment to Andrology is a testament to his dedication to reproductive medicine.
  • With over 160 peer-reviewed publications and numerous awards, Dr. Yan is a committed researcher and educator.
  • Dr. Yan's vision for Andrology is to enhance its global influence and implement innovative strategies.
  • His plans include prioritizing cutting-edge reviews, rewarding high-quality contributions, and fostering the next generation of researchers through the Trainee Reviewer Program.

MACRENE actives, the Leader in Clean Luxury Skincare, Harnesses the Power of the Plant to Create Its Most Hydrating Face Cream Formulation

Retrieved on: 
Tuesday, April 2, 2024
Cosmetics, Retail, Specialty, Other Retail, Cream, Mineral oil, Neiman Marcus, Longevity, Resveratrol, Petroleum, Moda Operandi, Research, Reproduction, Doctor of Philosophy, Skin, Montauk Highway, FAAD, Multimedia, LED, Work

MACRENE actives , the cleanest, scientifically active and clinically proven luxury skincare brand founded by world-renowned dermatologist and scientist Dr. Macrene Alexiades MD, PhD.

Key Points: 
  • MACRENE actives , the cleanest, scientifically active and clinically proven luxury skincare brand founded by world-renowned dermatologist and scientist Dr. Macrene Alexiades MD, PhD.
  • FAAD , today announces the return of its richest, most luxurious formula, High Performance Face Cream Extra Rich , the do-it-all plant-derived powerhouse product for day and night.
  • Founded by lead dermatologist and clinical scientist Dr. Macrene Alexiades, MACRENE actives is inspired by over 25 years of work and research conducted by Dr. Alexiades.
  • The brand’s most recent development, High Performance Face Cream Extra Rich, delivers a lush dose of hydration that is ideal for night-time or post-procedure needs.

Redwire Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 14, 2024
Satellite, Technology, Aerospace, Manufacturing, Other Science, Research, Science, Forecasting, Growth, Gross income, Corporation, EAC, Acquisition, Reproduction, Table, Adjustment, RDW, Video game

Revenues for the fourth quarter of 2023 increased 18.2% to $63.5 million, as compared to $53.7 million for the fourth quarter of 2022.

Key Points: 
  • Revenues for the fourth quarter of 2023 increased 18.2% to $63.5 million, as compared to $53.7 million for the fourth quarter of 2022.
  • Comparable Revenues4 for the fourth quarter of 2023 increased 15.5% to $48.6 million, as compared to $42.0 million for the fourth quarter of 2022.
  • Book-to-bill3 ratio for the fourth quarter of 2023 was 2.81, as compared to 3.74 as of the fourth quarter of 2022.
  • ET on Friday, March 15, 2024 to review financial results for the fourth quarter and full year ended December 31, 2023.